| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1373323 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
Niacin is an effective drug for raising HDL cholesterol and reducing coronary risks, but patients show low compliance with treatment due to severe facial flushing upon taking the drug. A series of bicyclic pyrazole carboxylic acids were synthesized and tested for their ability to activate the niacin receptor. One analog, 23, showed improved potency and lacked flushing at doses that effectively altered the lipid profile of rats.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Darby Schmidt, Abigail Smenton, Subharekha Raghavan, Ester Carballo-Jane, Silvi Lubell, Tanya Ciecko, Tom G. Holt, Michael Wolff, Andrew Taggart, Larissa Wilsie, Mihajlo Krsmanovic, Ning Ren, Daniel Blom, Kang Cheng, Peggy E. McCann, M. Gerard Waters,